Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.


All category news

  • CDC official on why the flu is near-epidemic, peaking early this year

    January 11, 2018 1:26 AM 40

    A dangerous flu has been spreading rapidly across the U.S., escalating flu season earlier than usual, and to near-epidemic levels, according to the CDC. Earlier today, Dr. Daniel B. Jernigan from the CDC, joined "GMA" to address the concerns and misconceptions about this year's flu cycle. "That's about a month earlier than it normally would be peaking

  • Japan reports first suspected bird flu case in poultry this winter

    January 10, 2018 8:34 AM 19

    TOKYO (Reuters) - Japan’s agriculture ministry on Wednesday reported a suspected case of bird flu in Kagawa prefecture, western Japan, potentially marking the country’s first bird flu outbreak in poultry this winter. The ministry said chickens at a farm in the area of Sanuki city in Kagawa tested positive in a preliminary examination on Wednesday for highly

  • FDA expands use of Amgen's blockbuster drug

    January 5, 2018 3:48 PM 17

    (Reuters) - Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma. Xgeva has already been approved to treat a condition in which the calcium level in blood is above normal and giant cell tumor of the bone. Amgen reacquired sales rights to Xgeva along with two other

  • Badly strained UK hospitals to delay non-urgent procedures

    January 3, 2018 1:21 PM 89

    Officials say extreme seasonal pressure on Britain's hospital system means many non-urgent procedures must be put off for weeks. National Health Service England officials are telling hospitals to delay some procedures to free up staff and beds to deal with emergency patients. The restrictions are set to last until at least the end of January and are predicted

  • Novartis breast cancer therapy gets FDA breakthrough designation

    January 3, 2018 6:56 AM 28

    ZURICH (Reuters) - Novartis’s Kisqali (ribociclib) has won U.S. Food and Drug Administration breakthrough therapy designation for treating some breast cancer patients, the Swiss drugmaker said on Wednesday. The designation covers initial endocrine-based treatment of pre- or perimenopausal women with hormone-receptor positive, human epidermal growth factor

  • FDA issues recall on J&J heart device

    January 2, 2018 7:11 PM 32

    (Reuters) - The U.S. Food and Drug Administration on Tuesday issued a recall of a heart device made by a unit of Johnson & Johnson due to a faulty valve. The valve, which prevents blood from flowing back through it, is part of a device used to insert and position cardiovascular catheters in the heart. ( About 110 Agilis Steerable Introducer

  • Flu outbreak already reported in 36 states, CDC says

    December 29, 2017 7:53 PM 168

    In the last week of the year, 21 states experienced high influenza activity and other five qualified in the moderate range. (Kurhan) As many as 36 states across the U.S. have reported widespread influenza activity already, but epidemiologists say it is too soon to say how bad the flu season will be this year. The early start of the outbreaks, which usually

  • FDA approves Mylan's copy of Allergan's vaginal cream

    December 29, 2017 5:33 PM 27

    (Reuters) - Mylan NV said the U.S. Food and Drug Administration had granted it the approval for a generic version of Allergan’s Estrace cream for vaginal atrophy. The approval comes amid the FDA’s efforts to speed to market generic versions of complex drugs such as Mylan’s own EpiPen, an emergency allergy shot. Complex drugs include medicines like metered-dose

  • The Latest: Praise, contempt for Down syndrome abortion law

    December 22, 2017 7:19 PM 24

    An anti-abortion group says a new Ohio law banning doctors from performing abortions based on diagnoses of Down syndrome will give unborn babies with the genetic disorder "a shot at life." But abortion rights groups argue the law will be another blow to women's constitutional right to legal abortion. Republican Gov. John Kasich (KAY'-sihk) signed the legislation

  • Novartis combo therapy for melanoma gets FDA priority review

    December 22, 2017 6:41 AM 35

    ZURICH (Reuters) - The U.S. Food and Drug Administration has granted priority review for Novartis’s Tafinlar in combination with Mekinist for treating some patients with advanced melanoma, the Swiss drugmaker said on Friday. The review covers the combination therapy for the adjuvant treatment of patients with stage III melanoma with BRAF V600E or V600K mutations